| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 2 |
| 1 | ACETAMINOPHEN 500MG | 2 |
| 2 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 2 |
| 3 | BREXUCABTAGENE AUTOLEUCEL | 2 |
| 4 | CARBOPLATIN | 2 |
| 5 | CYTARABINE | 2 |
| 6 | ETOPOSIDE | 2 |
| 7 | FILGRASTIM | 2 |
| 8 | FLUDARABINE PHOSPHATE | 2 |
| 9 | GALSULFASE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BREXUCABTAGENE AUTOLEUCEL | 2 | 0.0009 |
| 1 | GALSULFASE | 2 | 0.0005 |
| 2 | INSULIN GLARGINE AND LIXISENATIDE | 1 | 0.0003 |
| 3 | LORLATINIB | 1 | 0.0001 |
| 4 | FILGRASTIM | 2 | 0.0001 |
| 5 | FLUDARABINE PHOSPHATE | 2 | 0.0001 |
| 6 | CYTARABINE | 2 | 0.0000 |
| 7 | ETOPOSIDE | 2 | 0.0000 |
| 8 | SULFAMETHOXAZOLE AND TRIMETHOPRIM | 2 | 0.0000 |
| 9 | CABOZANTINIB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 2 | 0.0001 |
| 1 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |
| 2 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 2 | 0.0000 |
| 3 | Leukocyte Growth Factor [EPC] | 2 | 0.0000 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 2 | 0.0000 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Azole Antifungal [EPC] | 1 | 0.0000 |
| 8 | Factor Xa Inhibitor [EPC] | 1 | 0.0000 |
| 9 | GLP-1 Receptor Agonist [EPC] | 1 | 0.0000 |